With an aging population the effects of Alzheimer's Disease on the population at large are significant. Damaging not just the individual but putting families under stress and stretching medical resources.
Researchers at the University of Aberdeen have developed novel compounds that can be used to label beta-amyloid protein in the brain. Beta-amyloid protein is one of the charactersitic biomarkers for Alzheimer's disease; the most common form of dementia among the elderly population
Alzheimer’s Disease .